Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: A 12-month randomized trial

Mark B. Sherwood, E. Randy Craven, Connie Chou, Harvey B. DuBiner, Amy L. Batoosingh, Rhett M. Schiffman, Scott M. Whitcup

Research output: Contribution to journal › Article › peer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: A 12-month randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences